Author:
Ohneda Kinuko,Ohneda Akira,Koizumi Fumiaki
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference18 articles.
1. Hypoglycemic action of 2-[2-(4,5-dihydro-1 H-imidazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquihydrate (DG-5128), a new hypoglycemic agent;Kameda;Arzneim. Forsch., Beiheft. Res.,1982
2. Studies of midaglizole (DG-5128) a new type of oral hypoglycemic drug in healthy subjects;Kawazu;Diabetes,1987
3. Comparative study on the effects of a hypoglycemic 2-substituted-2-imidazoline derivative (DG-5128) and tolbutamide on insulin secretion from an insulin synthesis in the isolated rat pancreatic islets;Kameda;Biochim. Biophys. Acta,1981
4. Insulin releasing action of 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate (DG-5128), a new orally effective hypoglycemic agent;Kameda;Acta Endocrinol.,1982
5. α-Adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats;Östenson;Am. J. Physiol.,1989
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献